DOI: 10.12890/2024_005067
Malakoplakia associated with diarrhoea and colonic lesions after rituximab treatment
Authors
dralshattiy@gmail.com
Keywords
Rituximab-associated colitis, malakoplakia, immunosuppression, diarrhoea, Michaelis-Gutmann bodiesAbstract
Malakoplakia is a rare granulomatous condition that occurs due to defective lysosomal digestion during phagocytosis and can mimic inflammatory bowel disease (IBD) or malignancies, particularly in immunosuppressed patients. We report the case of a 62-year-old male with IgG4-related orbitopathy, who developed persistent diarrhoea and colonic lesions 6 weeks after receiving rituximab therapy for nephrotic syndrome secondary to membranoproliferative glomerulonephritis. Colonoscopy revealed pancolitis with mucosal granularity, loss of vascular pattern, and small nodules, raising initial suspicion for IBD. However, histological analysis of colonic biopsies confirmed malakoplakia with the presence of Michaelis-Gutmann bodies, pathognomonic for this condition. The patient was treated with ciprofloxacin for 2 weeks, and steroids were discontinued, leading to complete symptom resolution and significant histological improvement. During follow-up, the number and size of white lesions decreased, and no Michaelis-Gutmann bodies were detected. This case underscores the importance of maintaining a broad differential diagnosis for gastrointestinal lesions in immunosuppressed patients, as misdiagnosis can result in inappropriate escalation of immunosuppressive therapy. Recognizing the characteristic histopathology of malakoplakia and linking it with clinical findings are critical for timely diagnosis and effective management. This report adds to the limited literature on rituximab-associated malakoplakia, highlighting the unique challenges in its diagnosis and treatment.
References
- Jung YS, Chung DY, Kim EJ, Cho NH. Ultrastructural evidence of the evolutional process in malakoplakia. Histol Histopathol 2020;35:177–184.
- Yared AR, Badran AH, Kamareddine MH, Ghosn Y, Khalil RB, El Ajamy K, et al. Colonic malakoplakia: A rare finding in a healthy male. Case Rep Gastroenterol 2018;12:453–456.
- Mallepally N, Abu-Sbeih H, Ahmed O, Chen E, Shafi MA, Neelapu SS, et al. Clinical features of rituximab-associated gastrointestinal toxicities. Am J Clin Oncol 2019;42:539–545.
- Yen JM, Soh NWY, Petersson F, Pandya G. Rectosigmoid malakoplakia. BMJ Case Rep 2017:bcr2017219464.
- Thorlacius H, Jerkeman A, Marginean FE, Toth E. Colorectal malakoplakia in a patient with hypogammaglobulinemia. Gastrointest Endosc 2018;88:563–565.
